- Home
- VTMX vs ALVO Comparison
VTMX vs ALVO Comparison
Compare VTMX & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTMX
- ALVO
- Stock Information
- Founded
- VTMX 1998
- ALVO 2013
- Country
- VTMX Mexico
- ALVO Luxembourg
- Employees
- VTMX N/A
- ALVO N/A
- Industry
- VTMX
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- VTMX
- ALVO Health Care
- Exchange
- VTMX Nasdaq
- ALVO Nasdaq
- Market Cap
- VTMX 2.3B
- ALVO 2.5B
- IPO Year
- VTMX 2023
- ALVO N/A
- Fundamental
- Price
- VTMX $27.44
- ALVO $8.07
- Analyst Decision
- VTMX Sell
- ALVO
- Analyst Count
- VTMX 2
- ALVO 0
- Target Price
- VTMX $29.50
- ALVO N/A
- AVG Volume (30 Days)
- VTMX 77.3K
- ALVO 481.1K
- Earning Date
- VTMX 10-23-2025
- ALVO 08-13-2025
- Dividend Yield
- VTMX 2.35%
- ALVO N/A
- EPS Growth
- VTMX N/A
- ALVO N/A
- EPS
- VTMX 0.04
- ALVO 0.22
- Revenue
- VTMX $263,061,301.00
- ALVO $562,478,000.00
- Revenue This Year
- VTMX $15.41
- ALVO $33.32
- Revenue Next Year
- VTMX $11.06
- ALVO $46.16
- P/E Ratio
- VTMX $70.96
- ALVO $37.15
- Revenue Growth
- VTMX 11.49
- ALVO 82.19
- 52 Week Low
- VTMX $21.30
- ALVO $7.35
- 52 Week High
- VTMX $30.07
- ALVO $13.70
- Technical
- Relative Strength Index (RSI)
- VTMX 44.51
- ALVO 40.69
- Support Level
- VTMX $27.15
- ALVO $7.97
- Resistance Level
- VTMX $28.03
- ALVO $8.16
- Average True Range (ATR)
- VTMX 0.47
- ALVO 0.34
- MACD
- VTMX -0.15
- ALVO -0.04
- Stochastic Oscillator
- VTMX 16.20
- ALVO 17.03
About VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)
Corporacion Inmobiliaria Vesta SAB de CV is an internally managed real estate company that owns, manages, develops, and leases industrial properties in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenue is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.